Hims & Hers stock plunges after FTC sues over alleged privacy violationsMSN·1 day ago, 12:52 PMHIMS+8.16%HIMY0.00%
HIMS Stock in Focus as FTC Lawsuit Takes Aim at Hims & Hers Business PracticesBarchart Option·20 hours agoHIMS+8.16%HIMZ+14.70%
Hims & Hers Stock Jumps on Vow to 'Vigorously' Defend Against FTC's 'Baseless Claims'Tip Ranks·21 hours agoHIMS+8.16%HIMZ+14.70%
03:07 ETHIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Lawprnewswire·4 hours agoHIMS+8.16%HIMZ+14.70%
Hims & Hers Health (HIMS) Receives a Hold from Truist FinancialTip Ranks·2 days ago, 09:26 PMHIMS+8.16%HIMY0.00%
FTC sues Hims & Hers for allegedly sharing patients’ medical data with advertisers Meta and SnapTechCrunch·22 hours agoHIMS+8.16%HIMZ+14.70%
HER: Strong H1 2026 results with accelerated investments, EBITDA growth, and positive outlookQuartr·1 day ago, 12:41 PMHIMS+8.16%HIMZ+14.70%
FTC Sues Hims & Hers Over Alleged Privacy And Billing Violationrttnews·14 hours agoHIMS+8.16%HIMZ+14.70%
FTC says Hims shared 'Sexual Wellness' pills order info with Meta. Accused of violating user privacy.Unusual Whales·18 hours agoHIMS+8.16%HIMY0.00%
Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds HigherUnusual Whales·Jul 23 at 03:49 PMHIMS+8.16%HIMZ+14.70%
Jim Cramer: Arista Is ‘Terrific,’ Also Likes This Consumer Cyclical Stockbenzinga_article·1 day ago, 07:12 AMLLY-4.55%ANET+8.26%
HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold ShoulderBarchart Option·Jul 24 at 02:47 PMHIMS+8.16%HIMZ+14.70%
Southpoint Capital Advisors LP Invests $10.38 Million in Hims & Hers Health, Inc. $HIMSMarket Beat·Jul 28 at 04:53 AMHIMS+8.16%HIMZ+14.70%
FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlightbenzinga_article·Jul 24 at 07:15 AMHIMS+8.16%HIMZ+14.70%
Hims & Hers Health: Regulatory Tailwinds and Peptide Opportunity Support Buy Rating, $40 Price Target ReiteratedTip Ranks·Jul 24 at 10:25 AMHIMS+8.16%HIMY0.00%
